Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-06

Clinical Trial Update: The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether angiotensin II receptor blockade affects kidney function and scarring after liver transplantation. The study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiotensin-II Receptor Blocker (angiotensin II receptor blocker)

Snippet

Sponsor: Mayo Clinic | Conditions: Liver Transplant Recipients | Phase 4 | Status: COMPLETED